News

The NASDAQ 100 Pre-Market Indicator is down -119.39 to 16,530.48. The total Pre-Market volume is currently 50,920,016 shares traded.

The following are the most active stocks for the pre-market session:

Seres Therapeutics, Inc. (MCRB) is +0.58 at $2.14, with 7,646,080 shares traded. As reported by Zacks, the current mean recommendation for MCRB is in the "buy range".

ProShares UltraPro Short QQQ (SQQQ) is +0.23 at $14.12, with 3,299,170 shares traded. This represents a 7.7% increase from its 52 Week Low.

Grifols, S.A. (GRFS) is -4.01 at $7.12, with 2,866,576 shares traded. As reported by Zacks, the current mean recommendation for GRFS is in the "buy range".

ProShares UltraPro QQQ (TQQQ) is -0.77 at $47.98, with 2,779,347 shares traded. This represents a 171.07% increase from its 52 Week Low.

Elicio Therapeutics, Inc. (ELTX) is +0.57 at $8.39, with 1,588,514 shares traded. ELTX's current last sale is 69.92% of the target price of $12.

Tilray Brands, Inc. (TLRY) is +0.14 at $2.48, with 1,519,174 shares traded. Smarter Analyst Reports: Tilray Acquires Breckenridge Distillery; Shares Gain

NIO Inc. (NIO) is -0.12 at $7.81, with 885,910 shares traded. NIO's current last sale is 74.74% of the target price of $10.45.

Juniper Networks, Inc. (JNPR) is +6.98 at $37.20, with 774,270 shares traded. JNPR's current last sale is 112.73% of the target price of $33.

CVS Health Corporation (CVS) is -0.06 at $80.62, with 728,469 shares traded. As reported by Zacks, the current mean recommendation for CVS is in the "buy range".

Bristol-Myers Squibb Company (BMY) is +0.4 at $52.19, with 694,453 shares traded. BMY's current last sale is 88.46% of the target price of $59.

Hewlett Packard Enterprise Company (HPE) is -1.33 at $16.39, with 598,646 shares traded. HPE's current last sale is 91.06% of the target price of $18.

Walmart Inc. (WMT) is -0.36 at $157.89, with 573,763 shares traded. As reported by Zacks, the current mean recommendation for WMT is in the "buy range".

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.